Finance

Lists
SAUHY:OTCMKTS
Straumann Holding ADR
USD 11,05
-0,54%
(-0,060) 1D
14 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SAUHY...
Open
USD 11,11
High
USD 11,11
Low
USD 10,98
Mkt. cap
14,76 mjd
Avg. vol.
88,72 k
Volume
126,49 k
52-wk high
USD 13,61
52-wk low
USD 9,44
Beta
1,62
Shares outstanding
1,59 mjd
No. of employees
12 k
Open
USD 11,11
High
USD 11,11
Low
USD 10,98
Mkt. cap
14,76 mjd
Avg. vol.
88,72 k
Volume
126,49 k
52-wk high
USD 13,61
52-wk low
USD 9,44
Beta
1,62
Shares outstanding
1,59 mjd
No. of employees
12 k
News stories
From web sources and news partners
Profile
Straumann Group is a Swiss company based in Basel manufacturing dental implants and specialized in related technologies. The group researches, develops, manufactures and supplies dental implants, instruments, biomaterials, CADCAM prosthetics, digital equipment, software, and clear aligners for applications in replacement, restorative, orthodontic and preventative dentistry. The Straumann Group also offers services to the dental profession worldwide, including training and education, which is provided in collaboration with the International Team for Implantology and the Instituto Latino Americano de Pesquisa e Ensino Odontológico. Its products and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners. Wikipedia
About Straumann Holding ADR
CEOGuillaume Daniellot | Guillaume Daniellot
Employees11,6 k
Founded1954
HeadquartersBasel, Basel City, Switserland
SectorMedical device
Website-
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
628,60 m
628,60 m
689,73 m
689,73 m
Cost of goods sold
201,43 m
201,43 m
203,84 m
203,84 m
Cost of revenue
201,43 m
201,43 m
203,84 m
203,84 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
280,83 m
280,83 m
316,62 m
316,62 m
Operating expense
277,79 m
277,79 m
312,52 m
312,52 m
Total operating expenses
479,22 m
479,22 m
516,36 m
516,36 m
Operating income
149,38 m
149,38 m
173,38 m
173,38 m
Other non operating income
-3,58 m
-3,58 m
-2,93 m
-2,93 m
EBT including unusual items
81,29 m
81,29 m
156,66 m
156,66 m
EBT excluding unusual items
136,50 m
136,50 m
154,39 m
154,39 m
Income tax expense
21,37 m
21,37 m
31,32 m
31,32 m
Effective tax rate
26,29%
26,29%
19,99%
19,99%
Other operating expenses
-3,04 m
-3,04 m
-4,10 m
-4,10 m
Net income
59,74 m
59,74 m
124,85 m
124,85 m
Net profit margin
9,50%
9,50%
18,10%
18,10%
Earnings per share
-
-
-
-
Interest and investment income
48,95 m
48,95 m
18,66 m
18,66 m
Interest expense
-38,43 m
-38,43 m
-31,47 m
-31,47 m
Net interest expenses
10,52 m
10,52 m
-12,81 m
-12,81 m
Depreciation and amortization charges
-
-
-
-
EBITDA
158,16 m
158,16 m
214,24 m
214,24 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme